SCHRODER INVESTMENT MANAGEMENT GROUP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1086619 London, X0

Position in MDGL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$20,861,326

+$3,943,768 QoQ

Shares Held

39,852

+37.2% QoQ

Ownership

0.173%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. MDGL ranks #6 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	163,898	$73,187,011
2	TECH	BIO-TECHNE Corp	1,197,214	$62,566,403
3	EXEL	Exelixis, Inc.	525,533	$22,540,109
4	ALNY	Alnylam Pharmaceuticals, Inc.	66,662	$22,056,454
5	SLNO	Soleno Therapeutics Inc	648,827	$21,722,727
6	MDGL	Madrigal Pharmaceuticals, Inc. This page	39,852	$20,861,326
7	INSM	INSMED Inc	119,958	$19,615,531
8	VERA	Vera Therapeutics, Inc.	484,381	$19,486,647

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,861,326	39,852	+37.2%	Shares	Sole	2026-05-14
2025-12-31	$16,917,558	29,051	+74.9%	Shares	Sole	2026-02-13
2025-09-30	$7,619,259	16,612	-50.0%	Shares	Sole	2025-11-13
2025-06-30	$10,049,766	33,207	+9.2%	Shares	Sole	2025-08-13
2025-03-31	$10,071,379	30,406	+175.2%	Shares	Sole	2025-05-13
2024-12-31	$3,408,772	11,047	-47.0%	Shares	Sole	2025-02-12
2024-09-30	$4,423,089	20,842	+64.0%	Shares	Sole	2024-11-13
2024-06-30	$3,560,273	12,708	-46.4%	Shares	Sole	2024-08-12
2024-03-31	$6,329,115	23,701	+29.5%	Shares	Sole	2024-05-14
2023-12-31	$4,234,254	18,300	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.